Carlos Martı́n

17.4k total citations · 1 hit paper
263 papers, 12.2k citations indexed

About

Carlos Martı́n is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Carlos Martı́n has authored 263 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Infectious Diseases, 127 papers in Epidemiology and 65 papers in Immunology. Recurrent topics in Carlos Martı́n's work include Tuberculosis Research and Epidemiology (143 papers), Mycobacterium research and diagnosis (105 papers) and Immune responses and vaccinations (38 papers). Carlos Martı́n is often cited by papers focused on Tuberculosis Research and Epidemiology (143 papers), Mycobacterium research and diagnosis (105 papers) and Immune responses and vaccinations (38 papers). Carlos Martı́n collaborates with scholars based in Spain, France and Germany. Carlos Martı́n's co-authors include Brigitte Gicquel, Peter W. M. Hermans, Sofía Samper, Nacho Aguiló, J D van Embden, Jesús Gonzalo‐Asensio, Kathleen D. Eisenach, Jeremy W. Dale, Ruth A. McAdam and Thomas M. Shinnick and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Carlos Martı́n

258 papers receiving 11.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1993 2.0k citations Brigitte Gicquel, Carlos Martı́n et al. profile →

Peers

Countries citing papers authored by Carlos Martı́n

Since Specialization

Citations

This map shows the geographic impact of Carlos Martı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Martı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Martı́n more than expected).

Fields of papers citing papers by Carlos Martı́n

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Martı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Martı́n. The network helps show where Carlos Martı́n may publish in the future.

Co-authorship network of co-authors of Carlos Martı́n

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Martı́n. A scholar is included among the top collaborators of Carlos Martı́n based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Martı́n. Carlos Martı́n is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates 2024 ·npj Vaccines ·Marco Polo Peralta Álvarez, (unknown), Andrew White, (unknown), Laura Sibley, Charlotte Sarfas, (unknown), Mike Dennis, (unknown), Stephanie A. Harris, Shuailin Li, Eugenia Puentes, Nacho Aguiló, Carlos Martı́n, (unknown), Helen McShane, Rachel Tanner	1
2	Tuberculosis in Spain: An opinion paper 2023 ·Revista Española de Quimioterapia ·Santiago Moreno, Fernando Rodríguez‐Artalejo, Julián Ruiz‐Galiana, Rafael Cantón, Pilar Ramos, Alejandra García‐Botella, Alberto García‐Lledó, Teresa Hernández‐Sampelayo, Javier Gómez‐Pavón, Juan González del Castillo, (unknown), (unknown), Manuel Martínez‐Sellés, José Molero, Begoña Santiago, José A. Caminero, Carlos Barrós, Darı́o Garcı́a de Viedma, Carlos Martı́n, Emilio Bouza	1
3	Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung 2023 ·Nature Communications ·(unknown), (unknown), Iñaki Robles‐Vera, Santiago Uranga, (unknown), Ana Belén Gómez, (unknown), Luna Minute, (unknown), (unknown), Gloria Esteso, Iratxe Uranga-Murillo, Maykel Arias, Julián Pardo, Carlos Martı́n, Mar Valés‐Gómez, Carlos del Fresno, David Sancho, Nacho Aguiló	18
4	Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown), Santiago Uranga, (unknown), Ana Belén Gómez, Denise Nardelli‐Haefliger, Carlos del Fresno, (unknown), Eugenia Puentes, Esteban Rodríguez, Mar Valés‐Gómez, Julián Pardo, David Sancho, Carlos Martı́n, Nacho Aguiló	13
5	BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies 2021 ·EBioMedicine ·(unknown), Jacobo Pardo‐Seco, (unknown), Nacho Aguiló, Ana Dacosta-Urbieta, Irene Rivero‐Calle, Jesús Gonzalo‐Asensio, Camille Locht, Luciana C. C. Leite, Carlos Martı́n, Federico Martinón‐Torres	11
6	Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection 2021 ·Cell Reports Medicine ·Karin Dijkman, Nacho Aguiló, Charelle Boot, Sam Hofman, Claudia C. Sombroek, Richard A. W. Vervenne, Clemens H. M. Kocken, Dessislava Marinova, Jelle Thole, Esteban Rodríguez, Michel Vierboom, Krista G. Haanstra, Eugenia Puentes, Carlos Martı́n, Frank A. W. Verreck	33
7	Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis 2021 ·Computational and Structural Biotechnology Journal ·(unknown), (unknown), Carmen Arnal, Santiago Uranga, (unknown), Luciana C. C. Leite, Carlos Martı́n, Jesús Gonzalo‐Asensio	8
8	TIPICO IX: report of the 9^th interactive infectious disease workshop on infectious diseases and vaccines 2019 ·Human Vaccines & Immunotherapeutics ·Federico Martinón‐Torres, Xavier Bosch, Rino Rappuoli, Shamez Ladhani, (unknown), Timo Vesikari, Adolfo Garcı́a-Sastre, Irene Rivero‐Calle, José Gómez Rial, Antonio Salas, Carlos Martı́n, Adam Finn, Robb Butler	20
9	Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures 2018 ·Proceedings of the National Academy of Sciences ·(unknown), María José Iglesias, Sofía Samper, Dessislava Marinova, Carlos Martı́n, Joaquín Sanz, Yamir Moreno	26
10	292 Specific causes of mortality in CF patients in France 2007-2010 2014 ·Journal of Cystic Fibrosis ·Pierre‐Régis Burgel, Cécile Hamard, Nicolas Carlier, (unknown), Michel Abély, D. Hubert, À. Munck, V. Boussaud, D. Grenet, Lydie Lemonnier, (unknown), Carlos Martı́n	1
11	Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain 2009 ·Clinical Microbiology and Infection ·Victoria Ortiz de la Tabla, (unknown), (unknown), (unknown), Carlos Martı́n, (unknown), (unknown), (unknown), Catalina Robledano, (unknown)	2
12	Activation as a framework for social policies towards lone parents: is there a continential specificity? 2007 ·The University of Bath Online Publications Store (The University of Bath) ·Trudie Knijn, Carlos Martı́n, Jane Millar	30
13	The Virulence-associated Two-component PhoP-PhoR System Controls the Biosynthesis of Polyketide-derived Lipids in Mycobacterium tuberculosis 2005 ·Journal of Biological Chemistry ·Jesús Gonzalo‐Asensio, (unknown), (unknown), Nathalie Barilone, Françoise Laval, Carlos Y. Soto, Nathalie Winter, Mamadou Daffé, Brigitte Gicquel, Carlos Martı́n, Mary Jackson	164
14	TUBERCULOSE: HISTÓRIA E PERSPECTIVAS ATUAIS 2003 ·LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) ·(unknown), Carlos Martı́n, (unknown)	0
15	The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. 2002 ·PubMed ·Edda De Rossi, Patrizio Arrigo, Marco Bellinzoni, (unknown), Carlos Martı́n, José A. Aı́nsa, Paola Guglierame, Giovanna Riccardi	89
16	Immediate Allergic Response in Small Airways 2001 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Stefan Uhlig, Carlos Martı́n	58
17	Epidemiological Evidence of the Spread of a Mycobacterium tuberculosis Strain of the Beijing Genotype on Gran Canaria Island 2001 ·American Journal of Respiratory and Critical Care Medicine ·José A. Caminero, María José Mellado, María Isolina Campos-Herrero, José Carlos del Castillo Rodríguez, (unknown), Pedro Cabrera, (unknown), Sofía Samper, Howard Takiff, (unknown), J. M. Díaz Pavón, Marı́a José Torres, Dick van Soolingen, Donald A. Enarson, Carlos Martı́n	142
18	[Emergence of Enterobacter aerogenes strains producing derepressed cephalosporinase at CHU in Limoges: molecular epidemiology by the RAPD technique]. 1997 ·PubMed ·(unknown), C. Grélaud, Carlos Martı́n, Françoise Denis	5
19	Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices 1996 ·European Respiratory Journal ·Carlos Martı́n, Stefan Uhlig, V. Ullrich	133
20	Use of conjugative and thermosensitive cloning vectors for transposon delivery toMycobacterium smegmatis 1995 ·FEMS Microbiology Letters ·Julie-Ann Gavigan, Christophe Guilhot, Brigitte Gicquel, Carlos Martı́n	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact